CAMS
MCID: CRB210
MIFTS: 29

Cerebrofacial Arteriovenous Metameric Syndrome (CAMS)

Categories: Cardiovascular diseases, Fetal diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Cerebrofacial Arteriovenous Metameric Syndrome

Summaries for Cerebrofacial Arteriovenous Metameric Syndrome

MalaCards based summary : Cerebrofacial Arteriovenous Metameric Syndrome, also known as cams, is related to cerebrofacial arteriovenous metameric syndrome type 3 and cerebrofacial arteriovenous metameric syndrome type 1. The drugs Tocopherol and Vitamin E have been mentioned in the context of this disorder. Affiliated tissues include endothelial, brain and breast.

Related Diseases for Cerebrofacial Arteriovenous Metameric Syndrome

Diseases in the Cerebrofacial Arteriovenous Metameric Syndrome family:

Cerebrofacial Arteriovenous Metameric Syndrome Type 3 Cerebrofacial Arteriovenous Metameric Syndrome Type 1

Diseases related to Cerebrofacial Arteriovenous Metameric Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 475)
# Related Disease Score Top Affiliating Genes
1 cerebrofacial arteriovenous metameric syndrome type 3 12.7
2 cerebrofacial arteriovenous metameric syndrome type 1 12.7
3 cataract 5, multiple types 12.2
4 wyburn-mason syndrome 12.1
5 cobb syndrome 11.7
6 cerebral cavernous malformations 11.4
7 hair whorl 10.9
8 arteriovenous malformation 10.8
9 subacute delirium 10.5
10 arteriovenous malformations of the brain 10.4
11 ataxia and polyneuropathy, adult-onset 10.4
12 hemangioma 10.4
13 capillary hemangioma 10.4
14 hypopituitarism 10.4
15 meningoencephalocele 10.4
16 mandibular arteriovenous malformation 10.4
17 colorectal cancer 10.3
18 neuroblastoma 1 10.3
19 suppression amblyopia 10.2
20 amblyopia 10.2
21 back pain 10.2
22 adenocarcinoma 10.2
23 osteoarthritis 10.2
24 breast cancer 10.2
25 ovarian cancer 10.2
26 squamous cell carcinoma 10.2
27 chronic pain 10.2
28 pancreatic cancer 10.2
29 scoliosis 10.2
30 measles 10.2
31 slipped capital femoral epiphysis 10.2
32 lung cancer 10.1
33 melanoma 10.1
34 myeloma, multiple 10.1
35 small cell cancer of the lung 10.1
36 inflammatory bowel disease 10.1
37 lymphoma 10.1
38 idiopathic scoliosis 10.1
39 bone resorption disease 10.1
40 adenoma 10.1
41 scoliosis, isolated 1 10.1
42 anxiety 10.1
43 rapidly involuting congenital hemangioma 10.1
44 migraine with or without aura 1 10.0
45 ocular motor apraxia 10.0
46 autoimmune disease 10.0
47 renal cell carcinoma, nonpapillary 10.0
48 helix syndrome 10.0
49 osteonecrosis 10.0
50 enophthalmos 10.0

Graphical network of the top 20 diseases related to Cerebrofacial Arteriovenous Metameric Syndrome:



Diseases related to Cerebrofacial Arteriovenous Metameric Syndrome

Symptoms & Phenotypes for Cerebrofacial Arteriovenous Metameric Syndrome

Drugs & Therapeutics for Cerebrofacial Arteriovenous Metameric Syndrome

Drugs for Cerebrofacial Arteriovenous Metameric Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 49)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tocopherol Approved, Investigational Phase 2 1406-66-2, 54-28-4 14986
2
Vitamin E Approved, Nutraceutical, Vet_approved Phase 2 59-02-9 14985
3 Tocotrienol Investigational Phase 2 6829-55-6
4 Trace Elements Phase 2
5 Micronutrients Phase 2
6 Antioxidants Phase 2
7 Vitamins Phase 2
8 Tocotrienols Phase 2
9 Tocopherols Phase 2
10 Nutrients Phase 2
11 Protective Agents Phase 2
12
Daunorubicin Approved 20830-81-3 30323
13
Anastrozole Approved, Investigational 120511-73-1 2187
14
Mitoxantrone Approved, Investigational 65271-80-9 4212
15
Idarubicin Approved 58957-92-9 42890
16
Etoposide Approved 33419-42-0 36462
17
Cytarabine Approved, Experimental, Investigational 147-94-4, 65-46-3 6253
18
Sargramostim Approved, Investigational 83869-56-1, 123774-72-1
19
Dasatinib Approved, Investigational 302962-49-8 3062316
20
Lenograstim Approved, Investigational 135968-09-1
21
Vitamin C Approved, Nutraceutical 50-81-7 54670067 5785
22
Homoharringtonine 285033
23 Hormones
24 Estrogens
25 Flax
26 Steroid Synthesis Inhibitors
27 Antineoplastic Agents, Hormonal
28 Hormone Antagonists
29 Estrogen Receptor Antagonists
30 Estrogen Antagonists
31 Aromatase Inhibitors
32 Phytoestrogens
33 Hormones, Hormone Substitutes, and Hormone Antagonists
34 Etoposide phosphate
35 Analgesics
36 Antineoplastic Agents, Phytogenic
37 Aclacinomycins
38 Anti-Infective Agents
39 Adjuvants, Immunologic
40 Protein Kinase Inhibitors
41 Topoisomerase Inhibitors
42 Peripheral Nervous System Agents
43 Antibiotics, Antitubercular
44 Anti-Bacterial Agents
45 Immunosuppressive Agents
46 Immunologic Factors
47 Antimetabolites
48 Antimetabolites, Antineoplastic
49 Antiviral Agents

Interventional clinical trials:

(show all 29)
# Name Status NCT ID Phase Drugs
1 Neuroplasticity of Brain-Asphyxiated Infants: Efficacy of Intervention Completed NCT00006516 Phase 2
2 Relaxation Response With Acupuncture for HIV Patients Completed NCT00064740 Phase 2
3 Effect of High Dose Vitamin E on Carotid Atherosclerosis Completed NCT00010699 Phase 2 Vitamin E
4 "Collaborative Assessment and Management of Suicidality" (CAMS) in Comparison to "Treatment as Usual" (TAU) for Suicidal Patients: a Randomized Controlled Trial Unknown status NCT02685943
5 Investigating the Effects of an Added Parent Component to Cognitive Behavior Therapy for Youth With Anxiety Disorders Unknown status NCT02160444
6 Efficacy Analysis of Comparison of CAMS-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia Completed NCT03165851
7 Patient and Provider Outcomes of E-Learning Training in Collaborative Assessment and Management of Suicidality Completed NCT00905827
8 CAMS Relational Agent System for Suicide Prevention Completed NCT03072875
9 Efficacy of Dialectical Behavior Therapy in Patient With Self Harming Behavior and Traits Within the Spectrum of Borderline Personality Disorder. Completed NCT01512602
10 A Randomized Clinical Trial of the Collaborative Assessment and Management of Suicidality Versus Enhanced Care as Usual for Suicidal Soldiers Completed NCT01300169
11 Intensive Outpatient Treatment for Suicidal Veterans: A Randomized Clinical Trial and Feasibility Investigation Completed NCT01334372
12 Developing Adaptive Interventions for Suicidal College Students Seeking Treatment - SMART Completed NCT02442869
13 Effect of Localized Muscle Cooling on Balance in Healthy Individuals Completed NCT03788135
14 A Double Arm Study to Evaluate the Effectiveness of NEM Compositions for the Treatment of Joint and Connective Tissue Pain Completed NCT00750854
15 Infection, Sepsis and Meningitis in Surinamese Neonates Completed NCT02486783
16 A Multi-Center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of Natural Eggshell Membrane (NEM) in the Treatment of Pain & Stiffness Associated With Moderate Osteoarthritis of the Knee Completed NCT00750477
17 A Single Arm Pilot Study to Evaluate the Effectiveness of Eggshell Membrane Compositions for the Treatment of Pain Associated With Connective Tissue and Joints Completed NCT00750230
18 Flaxseed vs. Aromatase Inhibitors: Breast Tumor Characteristics and Prognosis Completed NCT00612560 Anastrozole;Placebo
19 Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS Completed NCT00466050
20 Effects of Gait Rehabilitation With Dual Task in Patients With Parkinson's Disease: a Randomized Controlled Trial Completed NCT04038866
21 CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention Recruiting NCT03584386
22 Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion Recruiting NCT02845505
23 Pilot Study of the Collaborative Assessment and Management of Suicidality - Group (CAMS-G) Recruiting NCT03682406
24 The Efficiency of CAMS-2016 Trial for the Newly Diagnosed Pediatric Acute Myeloid Leukemia: A Prospective Single Centre Trial From China Recruiting NCT03173612 Dasatinib
25 Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals From Frederiksberg Municipality - A Prospective Cohort Study Recruiting NCT03472300
26 Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD Recruiting NCT02755103
27 Using Technology to Expand and Enhance Applied Behavioral Analysis Programs for Children With Autism in Military Families Active, not recruiting NCT01614275
28 Pilot Testing of Food Images in Children Enrolling by invitation NCT03338634
29 Improving Emotional Well-Being by Way of Alternative Therapies for Refugees Enrolling by invitation NCT03515564

Search NIH Clinical Center for Cerebrofacial Arteriovenous Metameric Syndrome

Genetic Tests for Cerebrofacial Arteriovenous Metameric Syndrome

Anatomical Context for Cerebrofacial Arteriovenous Metameric Syndrome

MalaCards organs/tissues related to Cerebrofacial Arteriovenous Metameric Syndrome:

41
Endothelial, Brain, Breast, Lung, Monocytes, Bone, Heart

Publications for Cerebrofacial Arteriovenous Metameric Syndrome

Articles related to Cerebrofacial Arteriovenous Metameric Syndrome:

(show top 50) (show all 2159)
# Title Authors PMID Year
1
Biodegradable nanoparticles exposing a short anti-FLT1 peptide as antiangiogenic platform to complement docetaxel anticancer activity. 38
31147059 2019
2
Macrophages at CNS interfaces: ontogeny and function in health and disease. 38
31358892 2019
3
Enhanced storage stability of solid lipid nanoparticles by surface modification of comb-shaped amphiphilic inulin derivatives. 38
31170643 2019
4
Intrabody against prolyl hydroxylase 2 promotes angiogenesis by stabilizing hypoxia-inducible factor-1α. 38
31413262 2019
5
Complementary and alternative medicine for natural and treatment-induced vasomotor symptoms: An overview of systematic reviews and meta-analyses. 38
31383438 2019
6
Quality of life in patients with mild Alzheimer disease: the mediator role of mindfulness and spirituality. 38
31411042 2019
7
IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signaling. 38
31233202 2019
8
Isobaric tag for relative and absolute quantitation based quantitative proteomics reveals unique urinary protein profiles in patients with preeclampsia. 38
31232531 2019
9
Burden of Cancer Mortality in the Canadian Armed Forces, 1976-2012: A Retrospective Cohort Study. 38
31160349 2019
10
Comparison and evaluation of the efficacy of compressed SENSE (CS) and gradient- and spin-echo (GRASE) in breath-hold (BH) magnetic resonance cholangiopancreatography (MRCP). 38
31313426 2019
11
Pre-pregnancy maternal fasting plasma glucose levels in relation to time to pregnancy among the couples attempting first pregnancy. 38
31216361 2019
12
Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment. 38
31356713 2019
13
The Impact of Treatment Expectations on Exposure Process and Treatment Outcome in Childhood Anxiety Disorders. 38
31313062 2019
14
Adrenal insufficiency from steroid-containing complementary therapy: importance of detailed history 38
31352697 2019
15
Assessing the Reliability of the CAMS Rating Scale Using a Generalizability Study. 38
30474407 2019
16
Pan-caspase inhibitors induce necroptosis via ROS-mediated activation of mixed lineage kinase domain-like protein and p38 in classically activated macrophages. 38
31039349 2019
17
Surface ozone in the Doon Valley of the Himalayan foothills during spring. 38
31020519 2019
18
Combinatorial presentation of cartilage-inspired peptides on nanopatterned surfaces enables directed differentiation of human mesenchymal stem cells towards distinct articular chondrogenic phenotypes. 38
31060868 2019
19
A systematic review of efficacy of Collaborative Assessment and Management of Suicidality (CAMS) in managing suicide risk and deliberate self-harm in adult populations. 38
31184492 2019
20
Recent advances in the development of HBV capsid assembly modulators. 38
30952041 2019
21
Activation of WNT and CREB signaling pathways in human neuronal cells in response to the Omega-3 fatty acid docosahexaenoic acid (DHA). 38
31202891 2019
22
Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma. 38
31186696 2019
23
C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis. 38
30487650 2019
24
Racial differences in retinal neurodegeneration as a surrogate marker for cortical atrophy in multiple sclerosis. 38
30991300 2019
25
Genome-wide identification and expression analysis of calmodulin and calmodulin-like genes in apple (Malus × domestica). 38
31030028 2019
26
Hydroxysafflor yellow A attenuates high glucose-induced human umbilical vein endothelial cell dysfunction. 38
30873871 2019
27
Integrated omics profiling reveals novel patterns of epigenetic programming in cancer-associated myofibroblasts. 38
30624614 2019
28
Association between circulating cell adhesion molecules and risk of type 2 diabetes: A meta-analysis. 38
31280040 2019
29
Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort Study. 38
31053738 2019
30
Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice. 38
30388208 2019
31
Genome‑wide profiling of lncRNA and mRNA expression in CRSwNP. 38
30864741 2019
32
[Complementary and alternative medicines in cancer patients]. 38
31023481 2019
33
Safety Comparison of Two Enterovirus 71 (EV71) Inactivated Vaccines in Yiwu, China. 38
31079146 2019
34
Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins. 38
31091809 2019
35
Tissue-specific knockout of E-cadherin (Cdh1) in developing mouse gonads causes germ cells loss. 38
31100714 2019
36
Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay. 38
30761887 2019
37
Attentional bias and the Suicide Status Form: Behavioral perseveration of written responses. 38
31248578 2019
38
DNA Methylation Analysis of the Citrullus lanatus Response to Cucumber GreenMottle Mosaic Virus Infection by Whole-Genome Bisulfite Sequencing. 38
31067797 2019
39
Differential expression profiles of the transcriptome in bone marrow-derived cells in lung cancer revealed by next generation sequencing and bioinformatics. 38
30944628 2019
40
FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation. 38
31110200 2019
41
Deficiency of TREK-1 potassium channel exacerbates blood-brain barrier damage and neuroinflammation after intracerebral hemorrhage in mice. 38
31072336 2019
42
Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer. 38
30446971 2019
43
Cationic Amphiphiles with Specificity against Gram-Positive and Gram-Negative Bacteria: Chemical Composition and Architecture Combat Bacterial Membranes. 38
30888181 2019
44
The Use of Complementary and Alternative Medicines Among Surgical Patients: A Survey Study. 38
30033002 2019
45
Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma. 38
30685058 2019
46
Alternative Treatments for Atopic Dermatitis: An Update. 38
30511123 2019
47
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. 38
30885723 2019
48
Vitamin A deficiency execrates Lewis lung carcinoma via induction of type 2 innate lymphoid cells and alternatively activates macrophages. 38
31024701 2019
49
Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus. 38
30952707 2019
50
Managing suicidality within specialized care: A randomized controlled trial. 38
30771641 2019

Variations for Cerebrofacial Arteriovenous Metameric Syndrome

Expression for Cerebrofacial Arteriovenous Metameric Syndrome

Search GEO for disease gene expression data for Cerebrofacial Arteriovenous Metameric Syndrome.

Pathways for Cerebrofacial Arteriovenous Metameric Syndrome

GO Terms for Cerebrofacial Arteriovenous Metameric Syndrome

Sources for Cerebrofacial Arteriovenous Metameric Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....